Location History:
- Liverpool, GB (2017)
- Macclesfield, GB (2018 - 2023)
Company Filing History:
Years Active: 2017-2025
Title: Matilda Bingham: Innovator in Cancer Treatment
Introduction
Matilda Bingham is a prominent inventor based in Macclesfield, GB. She has made significant contributions to the field of medical research, particularly in the development of compounds that target the Wnt signaling pathway. With a total of seven patents to her name, Bingham's work is paving the way for innovative treatments in oncology.
Latest Patents
Among her latest patents is the invention of N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway. This invention focuses on compounds that serve as inhibitors of Porcupine (Porcn), a key component in the Wnt signaling pathway. The compounds developed by Bingham may be utilized in treating various conditions mediated by this pathway, including cancer, sarcoma, melanoma, skin cancer, hematological tumors, lymphoma, carcinoma, and leukemia. Additionally, these compounds have the potential to enhance the effectiveness of existing anti-cancer treatments.
Career Highlights
Bingham has worked with notable companies in the pharmaceutical industry, including Redx Pharma Limited and Jazz Pharmaceuticals Ireland Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her coworkers include Richard Testar and Inder Bhamra, who have played a role in her professional journey. Their collaboration has likely fostered an environment of innovation and creativity in their shared projects.
Conclusion
Matilda Bingham's contributions to the field of cancer treatment through her innovative patents highlight her role as a leading inventor. Her work continues to inspire advancements in medical research and treatment options for patients worldwide.